| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850748 | American Heart Journal | 2008 | 6 Pages |
Abstract
A number of promising antiplatelet therapies currently in advanced clinical testing offer hope for improving cardiovascular outcomes in patients with acute coronary syndromes and those undergoing percutaneous interventions. We review the preclinical pharmacology and selected ongoing clinical trials of promising novel platelet inhibitor therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dominick J. Angiolillo, Piera Capranzano,